{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:30:43Z","timestamp":1792665043719,"version":"4.5.0"},"reference-count":209,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T00:00:00Z","timestamp":1550102400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s00702-019-01975-4","type":"journal-article","created":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T07:47:29Z","timestamp":1550130449000},"page":"233-251","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Dementia spectrum disorders: lessons learnt from decades with PET research"],"prefix":"10.1007","volume":"126","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2225-0241","authenticated-orcid":false,"given":"Heather","family":"Wilson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gennaro","family":"Pagano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marios","family":"Politis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,14]]},"reference":[{"issue":"6","key":"1975_CR1","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1097\/WCO.0b013e3283168df0","volume":"21","author":"D Aarsland","year":"2008","unstructured":"Aarsland D, Beyer MK, Kurz MW (2008) Dementia in Parkinson\u2019s disease. Curr Opin Neurol 21(6):676\u2013682","journal-title":"Curr Opin Neurol"},{"issue":"4","key":"1975_CR2","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nrneurol.2017.27","volume":"13","author":"D Aarsland","year":"2017","unstructured":"Aarsland D et al (2017) Cognitive decline in Parkinson disease. Nat Rev Neurol 13(4):217\u2013231","journal-title":"Nat Rev Neurol"},{"issue":"11","key":"1975_CR3","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1001\/archneur.65.11.1509","volume":"65","author":"HJ Aizenstein","year":"2008","unstructured":"Aizenstein HJ et al (2008) Frequent amyloid deposition without significant cognitive impairment among the elderly. Arch Neurol 65(11):1509\u20131517","journal-title":"Arch Neurol"},{"issue":"Pt 12","key":"1975_CR4","doi-asserted-by":"publisher","first-page":"3734","DOI":"10.1093\/brain\/awv278","volume":"138","author":"A Altmann","year":"2015","unstructured":"Altmann A et al (2015) Regional brain hypometabolism is unrelated to regional amyloid plaque burden. Brain 138(Pt 12):3734\u20133746","journal-title":"Brain"},{"issue":"9","key":"1975_CR5","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1007\/s00259-013-2458-z","volume":"40","author":"J Arbizu","year":"2013","unstructured":"Arbizu J et al (2013) Automated analysis of FDG PET as a tool for single-subject probabilistic prediction and detection of Alzheimer\u2019s disease dementia. Eur J Nucl Med Mol Imaging 40(9):1394\u20131405","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"1975_CR6","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1093\/cercor\/1.1.103","volume":"1","author":"SE Arnold","year":"1991","unstructured":"Arnold SE et al (1991) The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer\u2019s disease. Cereb Cortex 1(1):103\u2013116","journal-title":"Cereb Cortex"},{"issue":"3 Pt 1","key":"1975_CR7","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1212\/WNL.42.3.631","volume":"42","author":"PV Arriagada","year":"1992","unstructured":"Arriagada PV et al (1992) Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer\u2019s disease. Neurology 42(3 Pt 1):631\u2013639","journal-title":"Neurology"},{"issue":"2","key":"1975_CR8","doi-asserted-by":"publisher","first-page":"e55031","DOI":"10.1371\/journal.pone.0055031","volume":"8","author":"DP Bagchi","year":"2013","unstructured":"Bagchi DP et al (2013) Binding of the radioligand SIL23 to alpha-synuclein fibrils in Parkinson disease brain tissue establishes feasibility and screening approaches for developing a Parkinson disease imaging agent. PLoS One 8(2):e55031","journal-title":"PLoS One"},{"issue":"supplement 1","key":"1975_CR9","first-page":"630","volume":"58","author":"O Barret","year":"2017","unstructured":"Barret O et al (2017) Initial clinical pet studies with the novel tau agent 18-F PI-2620 IN Alzheimer\u2019s disease and controls. J Nucl Med 58(supplement 1):630","journal-title":"J Nucl Med"},{"issue":"4558","key":"1975_CR10","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1126\/science.7046051","volume":"217","author":"RT Bartus","year":"1982","unstructured":"Bartus RT et al (1982) The cholinergic hypothesis of geriatric memory dysfunction. Science 217(4558):408\u2013414","journal-title":"Science"},{"issue":"9","key":"1975_CR11","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa1202753","volume":"367","author":"RJ Bateman","year":"2012","unstructured":"Bateman RJ et al (2012) Clinical and biomarker changes in dominantly inherited Alzheimer\u2019s disease. N Engl J Med 367(9):795\u2013804","journal-title":"N Engl J Med"},{"issue":"12","key":"1975_CR12","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1212\/01.wnl.0000219668.47116.e6","volume":"66","author":"DA Bennett","year":"2006","unstructured":"Bennett DA et al (2006) Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology 66(12):1837\u20131844","journal-title":"Neurology"},{"issue":"47","key":"1975_CR13","doi-asserted-by":"publisher","first-page":"E4502","DOI":"10.1073\/pnas.1317918110","volume":"110","author":"TL Benzinger","year":"2013","unstructured":"Benzinger TL et al (2013) Regional variability of imaging biomarkers in autosomal dominant Alzheimer\u2019s disease. Proc Natl Acad Sci USA 110(47):E4502\u2013E4509","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"1975_CR14","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/S0149-7634(03)00070-8","volume":"27","author":"J Berger-Sweeney","year":"2003","unstructured":"Berger-Sweeney J (2003) The cholinergic basal forebrain system during development and its influence on cognitive processes: important questions and potential answers. Neurosci Biobehav Rev 27(4):401\u2013411","journal-title":"Neurosci Biobehav Rev"},{"issue":"12","key":"1975_CR15","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1002\/acn3.366","volume":"3","author":"WR Bevan Jones","year":"2016","unstructured":"Bevan Jones WR et al (2016) [18F]AV-1451 PET in behavioral variant frontotemporal dementia due to MAPT mutation. Ann Clin Transl Neurol 3(12):940\u2013947","journal-title":"Ann Clin Transl Neurol"},{"issue":"1","key":"1975_CR16","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1001\/archneur.1995.00540250089017","volume":"52","author":"LM Bierer","year":"1995","unstructured":"Bierer LM et al (1995a) Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer\u2019s disease. Arch Neurol 52(1):81\u201388","journal-title":"Arch Neurol"},{"issue":"2","key":"1975_CR17","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1046\/j.1471-4159.1995.64020749.x","volume":"64","author":"LM Bierer","year":"1995","unstructured":"Bierer LM et al (1995b) Neurochemical correlates of dementia severity in Alzheimer\u2019s disease: relative importance of the cholinergic deficits. J Neurochem 64(2):749\u2013760","journal-title":"J Neurochem"},{"key":"1975_CR18","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1742-2094-11-25","volume":"11","author":"AM Birch","year":"2014","unstructured":"Birch AM, Katsouri L, Sastre M (2014) Modulation of inflammation in transgenic models of Alzheimer\u2019s disease. J Neuroinflammation 11:25","journal-title":"J Neuroinflammation"},{"issue":"12","key":"1975_CR19","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1001\/archneur.60.12.1745","volume":"60","author":"NI Bohnen","year":"2003","unstructured":"Bohnen NI et al (2003) Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study. Arch Neurol 60(12):1745\u20131748","journal-title":"Arch Neurol"},{"issue":"1\u20132","key":"1975_CR20","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.neulet.2005.01.031","volume":"380","author":"NI Bohnen","year":"2005","unstructured":"Bohnen NI et al (2005) Cognitive correlates of alterations in acetylcholinesterase in Alzheimer\u2019s disease. Neurosci Lett 380(1\u20132):127\u2013132","journal-title":"Neurosci Lett"},{"issue":"2","key":"1975_CR21","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1007\/s00415-005-0971-0","volume":"253","author":"NI Bohnen","year":"2006","unstructured":"Bohnen NI et al (2006) Cognitive correlates of cortical cholinergic denervation in Parkinson\u2019s disease and parkinsonian dementia. J Neurol 253(2):242\u2013247","journal-title":"J Neurol"},{"issue":"4","key":"1975_CR22","doi-asserted-by":"publisher","first-page":"573","DOI":"10.2967\/jnumed.106.036764","volume":"48","author":"H Boutin","year":"2007","unstructured":"Boutin H et al (2007) 11C-DPA-713: a novel peripheral benzodiazepine receptor PET ligand for in vivo imaging of neuroinflammation. J Nucl Med 48(4):573\u2013581","journal-title":"J Nucl Med"},{"issue":"Suppl 2","key":"1975_CR23","doi-asserted-by":"publisher","first-page":"S742","DOI":"10.1002\/mds.22581","volume":"24","author":"DJ Brooks","year":"2009","unstructured":"Brooks DJ (2009) Imaging amyloid in Parkinson\u2019s disease dementia and dementia with Lewy bodies with positron emission tomography. Mov Disord 24(Suppl 2):S742\u2013S747","journal-title":"Mov Disord"},{"issue":"5999","key":"1975_CR24","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1126\/science.1195227","volume":"329","author":"J Burre","year":"2010","unstructured":"Burre J et al (2010) Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro. Science 329(5999):1663\u20131667","journal-title":"Science"},{"issue":"6","key":"1975_CR25","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1002\/ana.20332","volume":"56","author":"A Cagnin","year":"2004","unstructured":"Cagnin A et al (2004) In vivo detection of microglial activation in frontotemporal dementia. Ann Neurol 56(6):894\u2013897","journal-title":"Ann Neurol"},{"key":"1975_CR26","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1600-0404.2006.00694.x","volume":"185","author":"A Cagnin","year":"2006","unstructured":"Cagnin A et al (2006) In vivo evidence for microglial activation in neurodegenerative dementia. Acta Neurol Scand Suppl 185:107\u2013114","journal-title":"Acta Neurol Scand Suppl"},{"issue":"3","key":"1975_CR27","doi-asserted-by":"publisher","first-page":"468","DOI":"10.2967\/jnumed.108.058669","volume":"50","author":"F Chauveau","year":"2009","unstructured":"Chauveau F et al (2009) Comparative evaluation of the translocator protein radioligands 11C-DPA-713, 18F-DPA-714, and 11C-PK11195 in a rat model of acute neuroinflammation. J Nucl Med 50(3):468\u2013476","journal-title":"J Nucl Med"},{"issue":"2","key":"1975_CR28","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3233\/JAD-122059","volume":"34","author":"DT Chien","year":"2013","unstructured":"Chien DT et al (2013) Early clinical PET imaging results with the novel PHF-tau radioligand [F-18]-T807. J Alzheimers Dis 34(2):457\u2013468","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"1975_CR29","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1212\/WNL.0000000000002892","volume":"87","author":"H Cho","year":"2016","unstructured":"Cho H et al (2016) Tau PET in Alzheimer disease and mild cognitive impairment. Neurology 87(4):375\u2013383","journal-title":"Neurology"},{"issue":"11","key":"1975_CR30","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1212\/WNL.0000000000004364","volume":"89","author":"H Cho","year":"2017","unstructured":"Cho H et al (2017) 18F-AV-1451 binds to motor-related subcortical gray and white matter in corticobasal syndrome. Neurology 89(11):1170\u20131178","journal-title":"Neurology"},{"issue":"10","key":"1975_CR31","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1002\/jnr.22392","volume":"88","author":"R Clare","year":"2010","unstructured":"Clare R et al (2010) Synapse loss in dementias. J Neurosci Res 88(10):2083\u20132090","journal-title":"J Neurosci Res"},{"issue":"47","key":"1975_CR32","doi-asserted-by":"publisher","first-page":"14770","DOI":"10.1523\/JNEUROSCI.3669-09.2009","volume":"29","author":"AD Cohen","year":"2009","unstructured":"Cohen AD et al (2009) Basal cerebral metabolism may modulate the cognitive effects of Abeta in mild cognitive impairment: an example of brain reserve. J Neurosci 29(47):14770\u201314778","journal-title":"J Neurosci"},{"issue":"5","key":"1975_CR33","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1002\/jlcr.3496","volume":"60","author":"TL Collier","year":"2017","unstructured":"Collier TL et al (2017) cGMP production of the radiopharmaceutical [18 F]MK-6240 for PET imaging of human neurofibrillary tangles. J Labelled Comp Radiopharm 60(5):263\u2013269","journal-title":"J Labelled Comp Radiopharm"},{"issue":"2\u20133","key":"1975_CR34","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1159\/000354670","volume":"13","author":"Y Compta","year":"2014","unstructured":"Compta Y et al (2014) The significance of alpha-synuclein, amyloid-beta and tau pathologies in Parkinson\u2019s disease progression and related dementia. Neurodegener Dis 13(2\u20133):154\u2013156","journal-title":"Neurodegener Dis"},{"issue":"6","key":"1975_CR35","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s00401-014-1349-0","volume":"128","author":"JF Crary","year":"2014","unstructured":"Crary JF et al (2014) Primary age-related tauopathy (PART): a common pathology associated with human aging. Acta Neuropathol 128(6):755\u2013766","journal-title":"Acta Neuropathol"},{"issue":"3","key":"1975_CR36","doi-asserted-by":"publisher","first-page":"415","DOI":"10.2967\/jnumed.111.094029","volume":"53","author":"Z Cselenyi","year":"2012","unstructured":"Cselenyi Z et al (2012) Clinical validation of 18F-AZD4694, an amyloid-beta-specific PET radioligand. J Nucl Med 53(3):415\u2013424","journal-title":"J Nucl Med"},{"issue":"2","key":"1975_CR37","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/0022-510X(87)90057-8","volume":"78","author":"CA Davies","year":"1987","unstructured":"Davies CA et al (1987) A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer\u2019s disease. J Neurol Sci 78(2):151\u2013164","journal-title":"J Neurol Sci"},{"issue":"3","key":"1975_CR38","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/0306-4522(94)90179-1","volume":"59","author":"H Vos De","year":"1994","unstructured":"De Vos H et al (1994) Imidazoline receptors, non-adrenergic idazoxan binding sites and alpha 2-adrenoceptors in the human central nervous system. Neuroscience 59(3):589\u2013598","journal-title":"Neuroscience"},{"key":"1975_CR39","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3389\/fphar.2016.00088","volume":"7","author":"LD Declercq","year":"2016","unstructured":"Declercq LD et al (2016) Drug development in Alzheimer\u2019s disease: the contribution of PET and SPECT. Front Pharmacol 7:88","journal-title":"Front Pharmacol"},{"issue":"10\u201311","key":"1975_CR40","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/S0531-5565(02)00141-9","volume":"37","author":"A Delacourte","year":"2002","unstructured":"Delacourte A et al (2002) Tau aggregation in the hippocampal formation: an ageing or a pathological process? Exp Gerontol 37(10\u201311):1291\u20131296","journal-title":"Exp Gerontol"},{"issue":"8","key":"1975_CR41","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/j.neurobiolaging.2003.10.007","volume":"25","author":"J Diehl","year":"2004","unstructured":"Diehl J et al (2004) Cerebral metabolic patterns at early stages of frontotemporal dementia and semantic dementia. A PET study. Neurobiol Aging 25(8):1051\u20131056","journal-title":"Neurobiol Aging"},{"issue":"1","key":"1975_CR42","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.neurobiolaging.2005.11.002","volume":"28","author":"J Diehl-Schmid","year":"2007","unstructured":"Diehl-Schmid J et al (2007) Decline of cerebral glucose metabolism in frontotemporal dementia: a longitudinal 18F-FDG-PET-study. Neurobiol Aging 28(1):42\u201350","journal-title":"Neurobiol Aging"},{"issue":"9","key":"1975_CR43","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1038\/mp.2014.9","volume":"19","author":"PM Doraiswamy","year":"2014","unstructured":"Doraiswamy PM et al (2014) Florbetapir F 18 amyloid PET and 36-month cognitive decline: a prospective multicenter study. Mol Psychiatry 19(9):1044\u20131051","journal-title":"Mol Psychiatry"},{"issue":"2","key":"1975_CR44","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.neuroimage.2007.09.020","volume":"39","author":"A Drzezga","year":"2008","unstructured":"Drzezga A et al (2008) Imaging of amyloid plaques and cerebral glucose metabolism in semantic dementia and Alzheimer\u2019s disease. Neuroimage 39(2):619\u2013633","journal-title":"Neuroimage"},{"issue":"7","key":"1975_CR45","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1212\/01.wnl.0000244749.20056.d4","volume":"68","author":"P Edison","year":"2007","unstructured":"Edison P et al (2007) Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDG PET study. Neurology 68(7):501\u2013508","journal-title":"Neurology"},{"issue":"3","key":"1975_CR46","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.nbd.2008.08.001","volume":"32","author":"P Edison","year":"2008","unstructured":"Edison P et al (2008) Microglia, amyloid, and cognition in Alzheimer\u2019s disease: an [11C](R)PK11195-PET and [11C]PIB-PET study. Neurobiol Dis 32(3):412\u2013419","journal-title":"Neurobiol Dis"},{"issue":"6","key":"1975_CR47","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1038\/npp.2012.255","volume":"38","author":"P Edison","year":"2013","unstructured":"Edison P et al (2013) Microglia, amyloid, and glucose metabolism in Parkinson\u2019s disease with and without dementia. Neuropsychopharmacology 38(6):938\u2013949","journal-title":"Neuropsychopharmacology"},{"key":"1975_CR48","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.neulet.2006.08.061","volume":"408","author":"C Eggers","year":"2006","unstructured":"Eggers C et al (2006) Cortical acetylcholine esterase activity and ApoE4 genotype in Alzheimer disease. Neurosci Lett 408:46\u201350","journal-title":"Neurosci Lett"},{"issue":"Pt 11","key":"1975_CR49","doi-asserted-by":"publisher","first-page":"2856","DOI":"10.1093\/brain\/awl178","volume":"129","author":"H Engler","year":"2006","unstructured":"Engler H et al (2006) Two-year follow-up of amyloid deposition in patients with Alzheimer\u2019s disease. Brain 129(Pt 11):2856\u20132866","journal-title":"Brain"},{"issue":"1","key":"1975_CR50","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/s00259-007-0523-1","volume":"35","author":"H Engler","year":"2008","unstructured":"Engler H et al (2008) In vivo amyloid imaging with PET in frontotemporal dementia. Eur J Nucl Med Mol Imaging 35(1):100\u2013106","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"Pt 12","key":"1975_CR51","doi-asserted-by":"publisher","first-page":"3685","DOI":"10.1093\/brain\/awv288","volume":"138","author":"Z Fan","year":"2015","unstructured":"Fan Z et al (2015) Longitudinal influence of microglial activation and amyloid on neuronal function in Alzheimer\u2019s disease. Brain 138(Pt 12):3685\u20133698","journal-title":"Brain"},{"issue":"11","key":"1975_CR52","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.2967\/jnumed.115.169078","volume":"57","author":"Z Fan","year":"2016","unstructured":"Fan Z et al (2016) Flutriciclamide (18F-GE180) PET: first-in-human PET study of novel third-generation in vivo marker of human translocator protein. J Nucl Med 57(11):1753\u20131759","journal-title":"J Nucl Med"},{"issue":"348","key":"1975_CR53","doi-asserted-by":"publisher","first-page":"348ra96","DOI":"10.1126\/scitranslmed.aaf6667","volume":"8","author":"SJ Finnema","year":"2016","unstructured":"Finnema SJ et al (2016) Imaging synaptic density in the living human brain. Sci Transl Med 8(348):348ra96","journal-title":"Sci Transl Med"},{"issue":"1\u20133","key":"1975_CR54","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.ejphar.2009.06.042","volume":"617","author":"MT Fodero-Tavoletti","year":"2009","unstructured":"Fodero-Tavoletti MT et al (2009) In vitro characterisation of BF227 binding to alpha-synuclein\/Lewy bodies. Eur J Pharmacol 617(1\u20133):54\u201358","journal-title":"Eur J Pharmacol"},{"issue":"Pt 4","key":"1975_CR55","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1093\/brain\/awr038","volume":"134","author":"MT Fodero-Tavoletti","year":"2011","unstructured":"Fodero-Tavoletti MT et al (2011) 18F-THK523: a novel in vivo tau imaging ligand for Alzheimer\u2019s disease. Brain 134(Pt 4):1089\u20131100","journal-title":"Brain"},{"issue":"7","key":"1975_CR56","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/j.nucmedbio.2012.03.001","volume":"39","author":"MT Fodero-Tavoletti","year":"2012","unstructured":"Fodero-Tavoletti MT et al (2012) In vitro characterization of [18F]-florbetaben, an Abeta imaging radiotracer. Nucl Med Biol 39(7):1042\u20131048","journal-title":"Nucl Med Biol"},{"issue":"1","key":"1975_CR57","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.neulet.2010.09.036","volume":"486","author":"H Fujishiro","year":"2010","unstructured":"Fujishiro H et al (2010) Distribution of cerebral amyloid deposition and its relevance to clinical phenotype in Lewy body dementia. Neurosci Lett 486(1):19\u201323","journal-title":"Neurosci Lett"},{"issue":"2","key":"1975_CR58","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.neurobiolaging.2010.03.011","volume":"33","author":"AJ Furst","year":"2012","unstructured":"Furst AJ et al (2012) Cognition, glucose metabolism and amyloid burden in Alzheimer\u2019s disease. Neurobiol Aging 33(2):215\u2013225","journal-title":"Neurobiol Aging"},{"issue":"2\u20133","key":"1975_CR59","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0304-3940(98)00265-1","volume":"247","author":"JA Garcia-Sevilla","year":"1998","unstructured":"Garcia-Sevilla JA et al (1998) Imidazoline receptor proteins in brains of patients with Alzheimer\u2019s disease. Neurosci Lett 247(2\u20133):95\u201398","journal-title":"Neurosci Lett"},{"issue":"18","key":"1975_CR60","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1212\/WNL.0b013e3181dc1a55","volume":"74","author":"S Gilman","year":"2010","unstructured":"Gilman S et al (2010) Cerebral cortical and subcortical cholinergic deficits in parkinsonian syndromes. Neurology 74(18):1416\u20131423","journal-title":"Neurology"},{"key":"1975_CR61","doi-asserted-by":"crossref","unstructured":"Gomperts SN et al., Tau positron emission tomographic imaging in the Lewy body diseases. JAMA Neurol, 2016","DOI":"10.1001\/jamaneurol.2016.3338"},{"issue":"12","key":"1975_CR62","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1212\/01.wnl.0000326146.60732.d6","volume":"71","author":"SN Gomperts","year":"2008","unstructured":"Gomperts SN et al (2008) Imaging amyloid deposition in Lewy body diseases. Neurology 71(12):903\u2013910","journal-title":"Neurology"},{"issue":"8","key":"1975_CR63","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1002\/mds.25048","volume":"27","author":"SN Gomperts","year":"2012","unstructured":"Gomperts SN et al (2012) Brain amyloid and cognition in Lewy body diseases. Mov Disord 27(8):965\u2013973","journal-title":"Mov Disord"},{"key":"1975_CR64","unstructured":"Gomperts SM, Schultz A, Caso C (2015) [18F]T807 PET imaging of hyperphosphorylated tau to differentiate PSP from PD. In: Human amyloid imaging conference book of abstracts ID: 118"},{"issue":"1\u20132","key":"1975_CR65","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1159\/000441421","volume":"16","author":"SN Gomperts","year":"2016","unstructured":"Gomperts SN et al (2016) PET radioligands reveal the basis of dementia in parkinson\u2019s disease and dementia with Lewy bodies. Neurodegener Dis 16(1\u20132):118\u2013124","journal-title":"Neurodegener Dis"},{"issue":"7","key":"1975_CR66","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1007\/s00259-015-3035-4","volume":"42","author":"R Harada","year":"2015","unstructured":"Harada R et al (2015) [(18)F]THK-5117 PET for assessing neurofibrillary pathology in Alzheimer\u2019s disease. Eur J Nucl Med Mol Imaging 42(7):1052\u20131061","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"1975_CR67","doi-asserted-by":"publisher","first-page":"208","DOI":"10.2967\/jnumed.115.164848","volume":"57","author":"R Harada","year":"2016","unstructured":"Harada R et al (2016) 18-THK5351: a novel PET radiotracer for imaging neurofibrillary pathology in Alzheimer disease. J Nucl Med 57(2):208\u2013214","journal-title":"J Nucl Med"},{"issue":"3 Suppl","key":"1975_CR68","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3233\/JAD-2006-9S317","volume":"9","author":"J Hardy","year":"2006","unstructured":"Hardy J (2006) Alzheimer\u2019s disease: the amyloid cascade hypothesis: an update and reappraisal. J Alzheimers Dis 9(3 Suppl):151\u2013153","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"1975_CR69","doi-asserted-by":"publisher","first-page":"17","DOI":"10.2174\/187152506775268758","volume":"4","author":"GA Head","year":"2006","unstructured":"Head GA, Mayorov DN (2006) Imidazoline receptors, novel agents and therapeutic potential. Cardiovasc Hematol Agents Med Chem 4(1):17\u201332","journal-title":"Cardiovasc Hematol Agents Med Chem"},{"issue":"11","key":"1975_CR70","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1212\/01.wnl.0000191154.78131.f6","volume":"65","author":"R Hilker","year":"2005","unstructured":"Hilker R et al (2005) Dementia in Parkinson disease: functional imaging of cholinergic and dopaminergic pathways. Neurology 65(11):1716\u20131722","journal-title":"Neurology"},{"issue":"Pt 7","key":"1975_CR71","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1093\/brain\/awq120","volume":"133","author":"S Hirano","year":"2010","unstructured":"Hirano S et al (2010) Cholinergic imaging in corticobasal syndrome, progressive supranuclear palsy and frontotemporal dementia. Brain 133(Pt 7):2058\u20132068","journal-title":"Brain"},{"issue":"3","key":"1975_CR72","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1159\/000017227","volume":"11","author":"N Hirono","year":"2000","unstructured":"Hirono N et al (2000) Features of regional cerebral glucose metabolism abnormality in corticobasal degeneration. Dement Geriatr Cogn Disord 11(3):139\u2013146","journal-title":"Dement Geriatr Cogn Disord"},{"key":"1975_CR73","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.lfs.2009.02.029","volume":"86","author":"AG Horti","year":"2010","unstructured":"Horti AG et al (2010) Development of radioligands with optimized imaging properties for quantification of nicotinic acetylcholine receptors by positron emission tomography. Life Sci 86:575\u2013584","journal-title":"Life Sci"},{"issue":"10","key":"1975_CR74","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.parkreldis.2013.05.010","volume":"19","author":"J Horvath","year":"2013","unstructured":"Horvath J et al (2013) Neuropathology of dementia in a large cohort of patients with Parkinson\u2019s disease. Parkinsonism Relat Disord 19(10):864\u2013868; (discussion 864)","journal-title":"Parkinsonism Relat Disord"},{"issue":"1\u20132","key":"1975_CR75","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0022-510X(02)00102-8","volume":"199","author":"K Hosaka","year":"2002","unstructured":"Hosaka K et al (2002) Voxel-based comparison of regional cerebral glucose metabolism between PSP and corticobasal degeneration. J Neurol Sci 199(1\u20132):67\u201371","journal-title":"J Neurol Sci"},{"issue":"10","key":"1975_CR76","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.2967\/jnumed.115.171678","volume":"57","author":"ED Hostetler","year":"2016","unstructured":"Hostetler ED et al (2016) Preclinical characterization of 18F-MK-6240, a promising PET tracer for in vivo quantification of human neurofibrillary tangles. J Nucl Med 57(10):1599\u20131606","journal-title":"J Nucl Med"},{"issue":"1","key":"1975_CR77","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.parkreldis.2012.07.002","volume":"19","author":"S Iannaccone","year":"2013","unstructured":"Iannaccone S et al (2013) In vivo microglia activation in very early dementia with Lewy bodies, comparison with Parkinson\u2019s disease. Parkinsonism Relat Disord 19(1):47\u201352","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"1975_CR78","doi-asserted-by":"publisher","first-page":"320","DOI":"10.2967\/jnumed.116.178996","volume":"58","author":"M Ikawa","year":"2017","unstructured":"Ikawa M et al (2017) 11C-ER176, a radioligand for 18-kDa translocator protein, has adequate sensitivity to robustly image all three affinity genotypes in human brain. J Nucl Med 58(2):320\u2013325","journal-title":"J Nucl Med"},{"issue":"Pt 6","key":"1975_CR79","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1093\/brain\/awn016","volume":"131","author":"MD Ikonomovic","year":"2008","unstructured":"Ikonomovic MD et al (2008) Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer\u2019s disease. Brain 131(Pt 6):1630\u20131645","journal-title":"Brain"},{"issue":"6","key":"1975_CR80","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1007\/s00401-003-0766-2","volume":"106","author":"K Imamura","year":"2003","unstructured":"Imamura K et al (2003) Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson\u2019s disease brains. Acta Neuropathol 106(6):518\u2013526","journal-title":"Acta Neuropathol"},{"issue":"6","key":"1975_CR81","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/0969-8051(94)90159-7","volume":"21","author":"T Irie","year":"1994","unstructured":"Irie T et al (1994) Design and evaluation of radioactive acetylcholine analogs for mapping brain acetylcholinesterase (AchE) in vivo. Nucl Med Biol 21(6):801\u2013808","journal-title":"Nucl Med Biol"},{"issue":"11","key":"1975_CR82","first-page":"1875","volume":"39","author":"K Ishii","year":"1998","unstructured":"Ishii K et al (1998a) Cerebral glucose metabolism in patients with frontotemporal dementia. J Nucl Med 39(11):1875\u20131878","journal-title":"J Nucl Med"},{"issue":"1","key":"1975_CR83","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1212\/WNL.51.1.125","volume":"51","author":"K Ishii","year":"1998","unstructured":"Ishii K et al (1998b) Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer\u2019s disease. Neurology 51(1):125\u2013130","journal-title":"Neurology"},{"issue":"1","key":"1975_CR84","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s12149-014-0911-0","volume":"29","author":"K Ishii","year":"2015","unstructured":"Ishii K et al (2015) Regional glucose metabolic reduction in dementia with Lewy bodies is independent of amyloid deposition. Ann Nucl Med 29(1):78\u201383","journal-title":"Ann Nucl Med"},{"issue":"2","key":"1975_CR85","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/nrn2967","volume":"12","author":"LM Ittner","year":"2011","unstructured":"Ittner LM, Gotz J (2011) Amyloid-beta and tau-a toxic pas de deux in Alzheimer\u2019s disease. Nat Rev Neurosci 12(2):65\u201372","journal-title":"Nat Rev Neurosci"},{"issue":"11","key":"1975_CR86","doi-asserted-by":"publisher","first-page":"3336","DOI":"10.1093\/brain\/awq277","volume":"133","author":"CR Jack Jr","year":"2010","unstructured":"Jack CR Jr et al (2010) Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer\u2019s disease. Brain 133(11):3336\u20133348","journal-title":"Brain"},{"issue":"19","key":"1975_CR87","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1001\/jama.2015.4668","volume":"313","author":"WJ Jansen","year":"2015","unstructured":"Jansen WJ et al (2015) Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis. Jama 313(19):1924\u20131938","journal-title":"Jama"},{"key":"1975_CR88","unstructured":"Johnson KB, Sepulcre J, Rentz D (2014) Tau PET: initial experience with F18 T807. In: Human amyloid imaging conference book of abstracts ID: 103"},{"issue":"1","key":"1975_CR89","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/ana.24546","volume":"79","author":"KA Johnson","year":"2016","unstructured":"Johnson KA et al (2016) Tau positron emission tomographic imaging in aging and early Alzheimer disease. Ann Neurol 79(1):110\u2013119","journal-title":"Ann Neurol"},{"issue":"4","key":"1975_CR90","doi-asserted-by":"publisher","first-page":"574","DOI":"10.2967\/jnumed.115.158519","volume":"57","author":"M Jonasson","year":"2016","unstructured":"Jonasson M et al (2016) Tracer Kinetic analysis of (S)-(1)(8)F-THK5117 as a PET tracer for assessing tau pathology. J Nucl Med 57(4):574\u2013581","journal-title":"J Nucl Med"},{"issue":"6","key":"1975_CR91","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s00401-016-1618-1","volume":"132","author":"KA Josephs","year":"2016","unstructured":"Josephs KA et al (2016) [18F]AV-1451 tau-PET uptake does correlate with quantitatively measured 4R-tau burden in autopsy-confirmed corticobasal degeneration. Acta Neuropathol 132(6):931\u2013933","journal-title":"Acta Neuropathol"},{"key":"1975_CR92","unstructured":"Juh R et al., Different metabolic patterns analysis of Parkinsonism on the 18F-FDG PET. Eur J, Radiol (2004) 51(3): pp.\u00a0223\u201333"},{"issue":"1\u20132","key":"1975_CR93","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.neulet.2005.03.057","volume":"383","author":"R Juh","year":"2005","unstructured":"Juh R et al (2005) Cerebral glucose metabolism in corticobasal degeneration comparison with progressive supranuclear palsy using statistical mapping analysis. Neurosci Lett 383(1\u20132):22\u201327","journal-title":"Neurosci Lett"},{"issue":"6","key":"1975_CR94","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1097\/00004714-200212000-00012","volume":"22","author":"V Kaasinen","year":"2002","unstructured":"Kaasinen V et al (2002) Regional effects of donepezil and rivastigmine on cortical acetylcholinesterase activity in Alzheimer\u2019s disease. J Clin Psychopharmacol 22(6):615\u2013620","journal-title":"J Clin Psychopharmacol"},{"issue":"4","key":"1975_CR95","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s00213-006-0447-7","volume":"188","author":"A Kadir","year":"2006","unstructured":"Kadir A et al (2006) PET imaging of cortical 11C-nicotine binding correlates with the cognitive function of attention in Alzheimer\u2019s disease. Psychopharmacology 188(4):509\u2013520","journal-title":"Psychopharmacology"},{"issue":"8","key":"1975_CR96","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/j.neurobiolaging.2007.02.020","volume":"29","author":"A Kadir","year":"2008","unstructured":"Kadir A et al (2008) PET imaging of the in vivo brain acetylcholinesterase activity and nicotine binding in galantamine-treated patients with AD. Neurobiol Aging 29(8):1204\u20131217","journal-title":"Neurobiol Aging"},{"issue":"9","key":"1975_CR97","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1016\/j.neurobiolaging.2011.09.024","volume":"33","author":"K Kantarci","year":"2012","unstructured":"Kantarci K et al (2012) Multimodality imaging characteristics of dementia with Lewy bodies. Neurobiol Aging 33(9):2091\u20132105","journal-title":"Neurobiol Aging"},{"issue":"1","key":"1975_CR98","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/ana.24825","volume":"81","author":"K Kantarci","year":"2017","unstructured":"Kantarci K et al (2017) AV-1451 tau and beta-amyloid positron emission tomography imaging in dementia with Lewy bodies. Ann Neurol 81(1):58\u201367","journal-title":"Ann Neurol"},{"issue":"2","key":"1975_CR99","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/ana.24188","volume":"76","author":"E Karran","year":"2014","unstructured":"Karran E, Hardy J (2014) A critique of the drug discovery and phase 3 clinical programs targeting the amyloid hypothesis for Alzheimer disease. Ann Neurol 76(2):185\u2013205","journal-title":"Ann Neurol"},{"issue":"1","key":"1975_CR100","doi-asserted-by":"publisher","first-page":"139","DOI":"10.2967\/jnumed.112.108258","volume":"54","author":"S Kealey","year":"2013","unstructured":"Kealey S et al (2013) Imaging imidazoline-I2 binding sites in porcine brain using 11C-BU99008. J Nucl Med 54(1):139\u2013144","journal-title":"J Nucl Med"},{"issue":"1","key":"1975_CR101","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/0304-3940(95)11270-7","volume":"186","author":"AM Kennedy","year":"1995","unstructured":"Kennedy AM et al (1995) Deficits in cerebral glucose metabolism demonstrated by positron emission tomography in individuals at risk of familial Alzheimer\u2019s disease. Neurosci Lett 186(1):17\u201320","journal-title":"Neurosci Lett"},{"issue":"Pt 9","key":"1975_CR102","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1093\/brain\/awh598","volume":"128","author":"A Kertesz","year":"2005","unstructured":"Kertesz A et al (2005) The evolution and pathology of frontotemporal dementia. Brain 128(Pt 9):1996\u20132005","journal-title":"Brain"},{"issue":"22","key":"1975_CR103","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1212\/WNL.0000000000003375","volume":"87","author":"A Kikuchi","year":"2016","unstructured":"Kikuchi A et al., In vivo visualization of tau deposits in corticobasal syndrome by 18F-THK5351 PET. Neurology (2016) 87(22): p.\u00a02309\u20132316","journal-title":"Neurology"},{"issue":"Pt 8","key":"1975_CR104","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1093\/brain\/awh539","volume":"128","author":"EJ Kim","year":"2005","unstructured":"Kim EJ et al (2005) Glucose metabolism in early onset versus late onset Alzheimer\u2019s disease: an SPM analysis of 120 patients. Brain 128(Pt 8):1790\u20131801","journal-title":"Brain"},{"issue":"8","key":"1975_CR105","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1002\/mds.20493","volume":"20","author":"RC Klein","year":"2005","unstructured":"Klein RC et al (2005) Direct comparison between regional cerebral metabolism in progressive supranuclear palsy and Parkinson\u2019s disease. Mov Disord 20(8):1021\u20131030","journal-title":"Mov Disord"},{"issue":"9","key":"1975_CR106","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1016\/j.neurobiolaging.2014.03.006","volume":"35","author":"DS Knopman","year":"2014","unstructured":"Knopman DS et al (2014) 18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons. Neurobiol Aging 35(9):2096\u20132106","journal-title":"Neurobiol Aging"},{"issue":"2","key":"1975_CR107","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.neulet.2012.02.083","volume":"514","author":"V Kotagal","year":"2012","unstructured":"Kotagal V et al (2012) Thalamic cholinergic innervation is spared in Alzheimer disease compared to parkinsonian disorders. Neurosci Lett 514(2):169\u2013172","journal-title":"Neurosci Lett"},{"issue":"Pt 7","key":"1975_CR108","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1093\/brain\/awt145","volume":"136","author":"WC Kreisl","year":"2013","unstructured":"Kreisl WC et al (2013) In vivo radioligand binding to translocator protein correlates with severity of Alzheimer\u2019s disease. Brain 136(Pt 7):2228\u20132238","journal-title":"Brain"},{"issue":"3","key":"1975_CR109","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/ana.410400309","volume":"40","author":"DE Kuhl","year":"1996","unstructured":"Kuhl DE et al (1996) In vivo mapping of cholinergic terminals in normal aging, Alzheimer\u2019s disease, and Parkinson\u2019s disease. Ann Neurol 40(3):399\u2013410","journal-title":"Ann Neurol"},{"issue":"4","key":"1975_CR110","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1212\/WNL.52.4.691","volume":"52","author":"DE Kuhl","year":"1999","unstructured":"Kuhl DE et al (1999) In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer\u2019s disease. Neurology 52(4):691\u2013699","journal-title":"Neurology"},{"issue":"7","key":"1975_CR111","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.neurobiolaging.2009.07.002","volume":"32","author":"SM Landau","year":"2011","unstructured":"Landau SM et al (2011) Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI. Neurobiol Aging 32(7):1207\u20131218","journal-title":"Neurobiol Aging"},{"issue":"4","key":"1975_CR112","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1001\/archneurol.2010.30","volume":"67","author":"JB Langbaum","year":"2010","unstructured":"Langbaum JB et al (2010) Hypometabolism in Alzheimer-affected brain regions in cognitively healthy Latino individuals carrying the apolipoprotein E epsilon4 allele. Arch Neurol 67(4):462\u2013468","journal-title":"Arch Neurol"},{"issue":"6","key":"1975_CR113","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1111\/nan.12092","volume":"40","author":"SB Lant","year":"2014","unstructured":"Lant SB et al (2014) Patterns of microglial cell activation in frontotemporal lobar degeneration. Neuropathol Appl Neurobiol 40(6):686\u2013696","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1975_CR114","unstructured":"Leung K (2007) N-Acetyl-N-(2-[11C]methoxybenzyl)-2-phenoxy-5-pyridinamine. In: Molecular imaging and contrast agent database (MICAD). National Center for Biotechnology Information (US), Bethesda, MD; 2004\u20132013 [Updated 25 Aug 2011]"},{"issue":"12","key":"1975_CR115","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1007\/s00259-008-0833-y","volume":"35","author":"Y Li","year":"2008","unstructured":"Li Y et al (2008) Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer\u2019s disease. Eur J Nucl Med Mol Imaging 35(12):2169\u20132181","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"Pt 1","key":"1975_CR116","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1093\/brain\/awt286","volume":"137","author":"YY Lim","year":"2014","unstructured":"Lim YY et al (2014) Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer\u2019s disease. Brain 137(Pt 1):221\u2013231","journal-title":"Brain"},{"issue":"supplement 2","key":"1975_CR117","first-page":"125","volume":"57","author":"T Lohith","year":"2016","unstructured":"Lohith T et al (2016) Preclinical evaluation and first-in-human dosimetry of [18F]MK-6240, a new PET tracer for in vivo quantification of human neurofibrillary tangles. J Nucl Med 57(supplement 2):125","journal-title":"J Nucl Med"},{"issue":"supplement 1","key":"1975_CR118","first-page":"277","volume":"58","author":"T Lohith","year":"2017","unstructured":"Lohith T et al (2017) Quantification of [18F]MK-6240, a new PET tracer targeting human neurofibrillary tangles (NFTs) in brain of healthy elderly and subjects with Alzheimer\u2019s disease. J Nucl Med 58(supplement 1):277","journal-title":"J Nucl Med"},{"issue":"22","key":"1975_CR119","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1212\/WNL.0000000000000467","volume":"82","author":"VJ Lowe","year":"2014","unstructured":"Lowe VJ et al (2014) Association of hypometabolism and amyloid levels in aging, normal subjects. Neurology 82(22):1959\u20131967","journal-title":"Neurology"},{"issue":"1","key":"1975_CR120","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s40478-016-0315-6","volume":"4","author":"VJ Lowe","year":"2016","unstructured":"Lowe VJ et al (2016) An autoradiographic evaluation of AV-1451 Tau PET in dementia. Acta Neuropathol Commun 4(1):58","journal-title":"Acta Neuropathol Commun"},{"issue":"4","key":"1975_CR121","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/syn.20027","volume":"52","author":"J Maeda","year":"2004","unstructured":"Maeda J et al (2004) Novel peripheral benzodiazepine receptor ligand [11C]DAA1106 for PET: an imaging tool for glial cells in the brain. Synapse 52(4):283\u2013291","journal-title":"Synapse"},{"issue":"3","key":"1975_CR122","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.neuroimage.2007.09.072","volume":"39","author":"W Maetzler","year":"2008","unstructured":"Maetzler W et al (2008) [11C]PIB binding in Parkinson\u2019s disease dementia. Neuroimage 39(3):1027\u20131033","journal-title":"Neuroimage"},{"issue":"1\u20132","key":"1975_CR123","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/S0006-8993(00)02945-0","volume":"886","author":"PJ Magistretti","year":"2000","unstructured":"Magistretti PJ (2000) Cellular bases of functional brain imaging: insights from neuron-glia metabolic coupling. Brain Res 886(1\u20132):108\u2013112","journal-title":"Brain Res"},{"issue":"3","key":"1975_CR124","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1001\/archneur.58.3.365","volume":"58","author":"NJ Maragakis","year":"2001","unstructured":"Maragakis NJ, Rothstein JD (2001) Glutamate transporters in neurologic disease. Arch Neurol 58(3):365\u2013370","journal-title":"Arch Neurol"},{"issue":"5","key":"1975_CR125","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1002\/ana.24517","volume":"78","author":"M Marquie","year":"2015","unstructured":"Marquie M et al (2015) Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue. Ann Neurol 78(5):787\u2013800","journal-title":"Ann Neurol"},{"issue":"6","key":"1975_CR126","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.neuron.2013.07.037","volume":"79","author":"M Maruyama","year":"2013","unstructured":"Maruyama M et al (2013) Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls. Neuron 79(6):1094\u20131108","journal-title":"Neuron"},{"key":"1975_CR127","doi-asserted-by":"crossref","unstructured":"Matsunaga S et al., Cholinesterase inhibitors for Lewy body disorders: a meta-analysis. Int J Neuropsychopharmacol, 2015. 19(2)","DOI":"10.1093\/ijnp\/pyv086"},{"issue":"2","key":"1975_CR128","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1148\/radiol.12112650","volume":"265","author":"J Mazere","year":"2012","unstructured":"Mazere J et al (2012) Progressive supranuclear palsy: in vivo SPECT imaging of presynaptic vesicular acetylcholine transporter with [123I]-iodobenzovesamicol. Radiology 265(2):537\u2013543","journal-title":"Radiology"},{"issue":"1","key":"1975_CR129","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1002\/glia.440070114","volume":"7","author":"PL McGeer","year":"1993","unstructured":"McGeer PL et al (1993) Microglia in degenerative neurological disease. Glia 7(1):84\u201392","journal-title":"Glia"},{"issue":"12","key":"1975_CR130","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","volume":"65","author":"IG McKeith","year":"2005","unstructured":"McKeith IG et al (2005) Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 65(12):1863\u20131872","journal-title":"Neurology"},{"issue":"3","key":"1975_CR131","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM et al (2011) The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the national institute on aging-Alzheimer\u2019s association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement 7(3):263\u2013269","journal-title":"Alzheimers Dement"},{"issue":"6","key":"1975_CR132","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s00401-016-1640-3","volume":"132","author":"CT McMillan","year":"2016","unstructured":"McMillan CT et al (2016) Multimodal evaluation demonstrates in vivo 18F-AV-1451 uptake in autopsy-confirmed corticobasal degeneration. Acta Neuropathol 132(6):935\u2013937","journal-title":"Acta Neuropathol"},{"issue":"1","key":"1975_CR133","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1097\/01.JGP.0000231744.69631.33","volume":"15","author":"MF Mendez","year":"2007","unstructured":"Mendez MF et al (2007) Preliminary findings: behavioral worsening on donepezil in patients with frontotemporal dementia. Am J Geriatr Psychiatry 15(1):84\u201387","journal-title":"Am J Geriatr Psychiatry"},{"issue":"9","key":"1975_CR134","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1136\/jnnp-2012-304644","volume":"84","author":"ZA Miller","year":"2013","unstructured":"Miller ZA et al (2013) TDP-43 frontotemporal lobar degeneration and autoimmune disease. J Neurol Neurosurg Psychiatry 84(9):956\u2013962","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"7","key":"1975_CR135","first-page":"1238","volume":"36","author":"S Minoshima","year":"1995","unstructured":"Minoshima S et al (1995) A diagnostic approach in Alzheimer\u2019s disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med 36(7):1238\u20131248","journal-title":"J Nucl Med"},{"issue":"3","key":"1975_CR136","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/ana.1133","volume":"50","author":"S Minoshima","year":"2001","unstructured":"Minoshima S et al (2001) Alzheimer\u2019s disease versus dementia with Lewy bodies: cerebral metabolic distinction with autopsy confirmation. Ann Neurol 50(3):358\u2013365","journal-title":"Ann Neurol"},{"key":"1975_CR137","unstructured":"Mintun MD, Pontecorvo M, Joshi A, Potential for PET imaging tau tracer 18F-AV-1451 (also known as 18F-T807) to detect neurodegenerative progression in Alzheimer\u2019s disease. Human amyloid imaging conference book of abstracts (2015) ID: 98"},{"issue":"9","key":"1975_CR138","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.2967\/jnumed.109.064030","volume":"50","author":"EM Mitsis","year":"2009","unstructured":"Mitsis EM et al (2009) 123I-5-IA-85380 SPECT imaging of nicotinic receptors in Alzheimer disease and mild cognitive impairment. J Nucl Med 50(9):1455\u20131463","journal-title":"J Nucl Med"},{"issue":"6","key":"1975_CR139","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.parkreldis.2010.04.004","volume":"16","author":"M Miyoshi","year":"2010","unstructured":"Miyoshi M et al (2010) In vivo detection of neuropathologic changes in presymptomatic MAPT mutation carriers: a PET and MRI study. Parkinsonism Relat Disord 16(6):404\u2013408","journal-title":"Parkinsonism Relat Disord"},{"issue":"9","key":"1975_CR140","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1111\/ene.13374","volume":"24","author":"I Moonga","year":"2017","unstructured":"Moonga I et al (2017) Hypertension is associated with worse cognitive function and hippocampal hypometabolism in Alzheimer\u2019s disease. Eur J Neurol 24(9):1173\u20131182","journal-title":"Eur J Neurol"},{"key":"1975_CR141","first-page":"112","volume":"8","author":"I Morales","year":"2014","unstructured":"Morales I et al (2014) Neuroinflammation in the pathogenesis of Alzheimer\u2019s disease. A rational framework for the search of novel therapeutic approaches. Front Cell Neurosci 8:112","journal-title":"Front Cell Neurosci"},{"issue":"supplement 1","key":"1975_CR142","first-page":"847","volume":"58","author":"A Mueller","year":"2017","unstructured":"Mueller A et al (2017) Characterization of the novel PET Tracer PI-2620 for the assessment of Tau pathology in Alzheimer\u2019s disease and other tauopathies. J Nucl Med 58(supplement 1):847","journal-title":"J Nucl Med"},{"issue":"12","key":"1975_CR143","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1007\/s00259-016-3464-8","volume":"43","author":"F Niccolini","year":"2016","unstructured":"Niccolini F, Politis M (2016) A systematic review of lessons learned from PET molecular imaging research in atypical parkinsonism. Eur J Nucl Med Mol Imaging 43(12):2244\u20132254","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"1975_CR144","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/00002093-199505000-00006","volume":"9","author":"A Nordberg","year":"1995","unstructured":"Nordberg A et al (1995) Kinetic analysis of regional (S)(-)11C-nicotine binding in normal and Alzheimer brains-in vivo assessment using positron emission tomography. Alzheimer Dis Assoc Disord 9(1):21\u201327","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"1975_CR145","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/BF02244748","volume":"115","author":"H Nyback","year":"1994","unstructured":"Nyback H et al (1994) PET studies of the uptake of (S)- and (R)-[11C]nicotine in the human brain: difficulties in visualizing specific receptor binding in vivo. Psychopharmacology 115:31\u201336","journal-title":"Psychopharmacology"},{"issue":"Pt 10","key":"1975_CR146","doi-asserted-by":"publisher","first-page":"3004","DOI":"10.1093\/brain\/awt195","volume":"136","author":"H Okada","year":"2013","unstructured":"Okada H et al (2013) Alterations in alpha4beta2 nicotinic receptors in cognitive decline in Alzheimer\u2019s aetiopathology. Brain 136(Pt 10):3004\u20133017","journal-title":"Brain"},{"issue":"12","key":"1975_CR147","first-page":"890","volume":"13","author":"N Okamura","year":"2010","unstructured":"Okamura N, Yanai K (2010) Florbetapir (18F), a PET imaging agent that binds to amyloid plaques for the potential detection of Alzheimer\u2019s disease. IDrugs 13(12):890\u2013899","journal-title":"IDrugs"},{"issue":"47","key":"1975_CR148","doi-asserted-by":"publisher","first-page":"10857","DOI":"10.1523\/JNEUROSCI.1738-05.2005","volume":"25","author":"N Okamura","year":"2005","unstructured":"Okamura N et al (2005) Quinoline and benzimidazole derivatives: candidate probes for in vivo imaging of tau pathology in Alzheimer\u2019s disease. J Neurosci 25(47):10857\u201310862","journal-title":"J Neurosci"},{"issue":"Pt 6","key":"1975_CR149","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1093\/brain\/awu064","volume":"137","author":"N Okamura","year":"2014","unstructured":"Okamura N et al (2014) Non-invasive assessment of Alzheimer\u2019s disease neurofibrillary pathology using 18F-THK5105 PET. Brain 137(Pt 6):1762\u20131771","journal-title":"Brain"},{"issue":"1","key":"1975_CR150","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1212\/01.wnl.0000338622.27876.0d","volume":"72","author":"A Okello","year":"2009","unstructured":"Okello A et al (2009) Microglial activation and amyloid deposition in mild cognitive impairment: a PET study. Neurology 72(1):56\u201362","journal-title":"Neurology"},{"issue":"2","key":"1975_CR151","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.ncl.2017.01.008","volume":"35","author":"NT Olney","year":"2017","unstructured":"Olney NT, Spina S, Miller BL (2017) Frontotemporal Dementia Neurol Clin 35(2):339\u2013374","journal-title":"Neurol Clin"},{"issue":"4","key":"1975_CR152","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1212\/WNL.0b013e31827f0889","volume":"80","author":"R Ossenkoppele","year":"2013","unstructured":"Ossenkoppele R et al (2013) Differential effect of APOE genotype on amyloid load and glucose metabolism in AD dementia. Neurology 80(4):359\u2013365","journal-title":"Neurology"},{"issue":"19","key":"1975_CR153","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1001\/jama.2015.4669","volume":"313","author":"R Ossenkoppele","year":"2015","unstructured":"Ossenkoppele R et al (2015) Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis. Jama 313(19):1939\u20131949","journal-title":"Jama"},{"issue":"Pt 5","key":"1975_CR154","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1093\/brain\/aww027","volume":"139","author":"R Ossenkoppele","year":"2016","unstructured":"Ossenkoppele R et al (2016) Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer\u2019s disease. Brain 139(Pt 5):1551\u20131567","journal-title":"Brain"},{"issue":"5","key":"1975_CR155","doi-asserted-by":"publisher","first-page":"838","DOI":"10.2967\/jnumed.113.131854","volume":"55","author":"CA Parker","year":"2014","unstructured":"Parker CA et al (2014) Evaluation of 11C-BU99008, a PET ligand for the imidazoline2 binding sites in rhesus brain. J Nucl Med 55(5):838\u2013844","journal-title":"J Nucl Med"},{"issue":"3","key":"1975_CR156","first-page":"781","volume":"140","author":"L Passamonti","year":"2017","unstructured":"Passamonti L et al (2017) 18F-AV-1451 positron emission tomography in Alzheimer\u2019s disease and progressive supranuclear palsy. Brain 140(3):781\u2013791","journal-title":"Brain"},{"issue":"2","key":"1975_CR157","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/0022-510X(77)90073-9","volume":"34","author":"EK Perry","year":"1977","unstructured":"Perry EK et al (1977) Neurotransmitter enzyme abnormalities in senile dementia. Choline acetyltransferase and glutamic acid decarboxylase activities in necropsy brain tissue. J Neurol Sci 34(2):247\u2013265","journal-title":"J Neurol Sci"},{"issue":"12","key":"1975_CR158","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1001\/archneurol.2009.266","volume":"66","author":"RC Petersen","year":"2009","unstructured":"Petersen RC et al (2009) Mild cognitive impairment: 10\u00a0years later. Arch Neurol 66(12):1447\u20131455","journal-title":"Arch Neurol"},{"issue":"2\u20133","key":"1975_CR159","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/0014-2999(91)90594-G","volume":"200","author":"MC Petit-Taboue","year":"1991","unstructured":"Petit-Taboue MC et al (1991) Brain kinetics and specific binding of [11C]PK 11195 to omega 3 sites in baboons: positron emission tomography study. Eur J Pharmacol 200(2\u20133):347\u2013351","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"1975_CR160","doi-asserted-by":"publisher","first-page":"396","DOI":"10.2967\/jnumed.113.124792","volume":"55","author":"M Petrou","year":"2014","unstructured":"Petrou M et al (2014) In vivo imaging of human cholinergic nerve terminals with (-)-5-(18)F-fluoroethoxybenzovesamicol: biodistribution, dosimetry, and tracer kinetic analyses. J Nucl Med 55(3):396\u2013404","journal-title":"J Nucl Med"},{"issue":"Pt 11","key":"1975_CR161","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.1093\/brain\/awm238","volume":"130","author":"KE Pike","year":"2007","unstructured":"Pike KE et al (2007) Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer\u2019s disease. Brain 130(Pt 11):2837\u20132844","journal-title":"Brain"},{"issue":"12","key":"1975_CR162","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/nrneurol.2014.205","volume":"10","author":"M Politis","year":"2014","unstructured":"Politis M (2014) Neuroimaging in Parkinson disease: from research setting to clinical practice. Nat Rev Neurol 10(12):708\u2013722","journal-title":"Nat Rev Neurol"},{"issue":"9","key":"1975_CR163","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1007\/s00415-012-6428-3","volume":"259","author":"M Politis","year":"2012","unstructured":"Politis M, Piccini P (2012) Positron emission tomography imaging in neurological disorders. J Neurol 259(9):1769\u20131780","journal-title":"J Neurol"},{"key":"1975_CR164","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3389\/fphar.2012.00096","volume":"3","author":"M Politis","year":"2012","unstructured":"Politis M, Su P, Piccini P (2012) Imaging of microglia in patients with neurodegenerative disorders. Front Pharmacol 3:96","journal-title":"Front Pharmacol"},{"key":"1975_CR165","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/bs.irn.2017.02.015","volume":"132","author":"M Politis","year":"2017","unstructured":"Politis M, Pagano G, Niccolini F (2017) Imaging in Parkinson\u2019s disease. Int Rev Neurobiol 132:233\u2013274","journal-title":"Int Rev Neurobiol"},{"issue":"6","key":"1975_CR166","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s00406-010-0184-0","volume":"261","author":"S Poljansky","year":"2011","unstructured":"Poljansky S et al (2011) A visual [18F]FDG-PET rating scale for the differential diagnosis of frontotemporal lobar degeneration. Eur Arch Psychiatry Clin Neurosci 261(6):433\u2013446","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"1975_CR167","unstructured":"Pontecorvo MD, Joshi A, Lu M (2015) Relationships between florbetapir PET amyloid and 18F AV-1451 (aka 18F-T807) PET tau binding in cognitively normal subjects and patients with cognitive impairments suspected of Alzheimer\u2019s disease. In: Human amyloid imaging conference book of abstracts ID: 98"},{"issue":"5","key":"1975_CR168","doi-asserted-by":"publisher","first-page":"375","DOI":"10.2165\/11533100-000000000-00000","volume":"24","author":"GD Rabinovici","year":"2010","unstructured":"Rabinovici GD, Miller BL (2010) Frontotemporal lobar degeneration: epidemiology, pathophysiology, diagnosis and management. CNS Drugs 24(5):375\u2013398","journal-title":"CNS Drugs"},{"issue":"15","key":"1975_CR169","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1212\/01.wnl.0000259035.98480.ed","volume":"68","author":"GD Rabinovici","year":"2007","unstructured":"Rabinovici GD et al (2007) 11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration. Neurology 68(15):1205\u20131212","journal-title":"Neurology"},{"issue":"Pt 2","key":"1975_CR170","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/brain\/awp326","volume":"133","author":"GD Rabinovici","year":"2010","unstructured":"Rabinovici GD et al (2010) Increased metabolic vulnerability in early-onset Alzheimer\u2019s disease is not related to amyloid burden. Brain 133(Pt 2):512\u2013528","journal-title":"Brain"},{"issue":"7","key":"1975_CR171","doi-asserted-by":"publisher","first-page":"P107","DOI":"10.1016\/j.jalz.2015.06.184","volume":"11","author":"GD Rabinovici","year":"2015","unstructured":"Raboinovici GD et al (2015) Tau PET with [18F]AV1451 in non-alzheimer's disease neurodegenerative syndromes. Alzheimer's Dementia J Alzheimer's Assoc 11(7):P107\u2013P109","journal-title":"Alzheimer's Dementia J Alzheimer's Assoc"},{"key":"1975_CR172","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1750-1326-8-19","volume":"8","author":"S Rayaprolu","year":"2013","unstructured":"Rayaprolu S et al (2013) TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson\u2019s disease. Mol Neurodegener 8:19","journal-title":"Mol Neurodegener"},{"issue":"9","key":"1975_CR173","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1007\/s00415-015-7711-x","volume":"262","author":"L Rocchi","year":"2015","unstructured":"Rocchi L, Niccolini F, Politis M (2015) Recent imaging advances in neurology. J Neurol 262(9):2182\u20132194","journal-title":"J Neurol"},{"issue":"7","key":"1975_CR174","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1007\/s00259-016-3349-x","volume":"43","author":"R Roy","year":"2016","unstructured":"Roy R et al (2016) Cholinergic imaging in dementia spectrum disorders. Eur J Nucl Med Mol Imaging 43(7):1376\u20131386","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"Suppl 1","key":"1975_CR175","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1007\/s00259-007-0701-1","volume":"35","author":"O Sabri","year":"2008","unstructured":"Sabri O et al (2008) Acetylcholine receptors in dementia and mild cognitive impairment. Eur J Nucl Med Mol Imaging 35(Suppl 1):S30\u2013S45","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"11","key":"1975_CR176","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.jalz.2016.01.003","volume":"12","author":"K Sander","year":"2016","unstructured":"Sander K et al (2016) Characterization of tau positron emission tomography tracer [18F]AV-1451 binding to postmortem tissue in Alzheimer\u2019s disease, primary tauopathies, and other dementias. Alzheimers Dement 12(11):1116\u20131124","journal-title":"Alzheimers Dement"},{"issue":"2","key":"1975_CR177","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1002\/ana.21706","volume":"66","author":"JA Schneider","year":"2009","unstructured":"Schneider JA et al (2009) The neuropathology of probable Alzheimer disease and mild cognitive impairment. Ann Neurol 66(2):200\u2013208","journal-title":"Ann Neurol"},{"key":"1975_CR178","unstructured":"Schultz A et al., (2015) Relationship between longitudinal amyloid accumulation and T807-Tau, In: Human amyloid imaging conference book of abstracts, Submission ID 101. 2015:68"},{"issue":"Pt 5","key":"1975_CR179","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1093\/brain\/aww023","volume":"139","author":"AJ Schwarz","year":"2016","unstructured":"Schwarz AJ et al (2016) Regional profiles of the candidate tau PET ligand 18F-AV-1451 recapitulate key features of Braak histopathological stages. Brain 139(Pt 5):1539\u20131550","journal-title":"Brain"},{"issue":"1","key":"1975_CR180","doi-asserted-by":"publisher","first-page":"a006189","DOI":"10.1101\/cshperspect.a006189","volume":"1","author":"A Serrano-Pozo","year":"2011","unstructured":"Serrano-Pozo A et al (2011) Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med 1(1):a006189","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"4","key":"1975_CR181","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1212\/WNL.0b013e3181ab2b58","volume":"73","author":"H Shimada","year":"2009","unstructured":"Shimada H et al (2009) Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET. Neurology 73(4):273\u2013278","journal-title":"Neurology"},{"issue":"2","key":"1975_CR182","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/mds.25286","volume":"28","author":"H Shimada","year":"2013","unstructured":"Shimada H et al (2013) beta-Amyloid in Lewy body disease is related to Alzheimer\u2019s disease-like atrophy. Mov Disord 28(2):169\u2013175","journal-title":"Mov Disord"},{"key":"1975_CR183","unstructured":"Shimada H, Shinotoh H, Sahara N (2015) Diagnostic utility and clinical significance of tau PET imaging with [11C]PBB3 in diverse tauopathies. In: Human amyloid imaging conference book of abstracts ID: 69"},{"issue":"13","key":"1975_CR184","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.2174\/1381612043384763","volume":"10","author":"H Shinotoh","year":"2004","unstructured":"Shinotoh H et al (2004) Acetylcholinesterase imaging: its use in therapy evaluation and drug design. Curr Pharm Des 10(13):1505\u20131517","journal-title":"Curr Pharm Des"},{"issue":"17","key":"1975_CR185","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1001\/jama.286.17.2120","volume":"286","author":"DH Silverman","year":"2001","unstructured":"Silverman DH et al (2001) Positron emission tomography in evaluation of dementia: regional brain metabolism and long-term outcome. Jama 286(17):2120\u20132127","journal-title":"Jama"},{"issue":"6","key":"1975_CR186","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1097\/01.yco.0000245747.53008.e2","volume":"19","author":"GW Small","year":"2006","unstructured":"Small GW, Kepe V, Barrio JR (2006) Seeing is believing: neuroimaging adds to our understanding of cerebral pathology. Curr Opin Psychiatry 19(6):564\u2013569","journal-title":"Curr Opin Psychiatry"},{"issue":"2","key":"1975_CR187","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S1474-4422(08)70019-X","volume":"7","author":"GW Small","year":"2008","unstructured":"Small GW et al (2008) Current and future uses of neuroimaging for cognitively impaired patients. Lancet Neurol 7(2):161\u2013172","journal-title":"Lancet Neurol"},{"issue":"8","key":"1975_CR188","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1212\/WNL.0000000000004264","volume":"89","author":"R Smith","year":"2017","unstructured":"Smith R et al (2017) In vivo retention of 18F-AV-1451 in corticobasal syndrome. Neurology 89(8):845\u2013853","journal-title":"Neurology"},{"issue":"6645","key":"1975_CR189","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini MG et al (1997) Alpha-synuclein in Lewy bodies. Nature 388(6645):839\u2013840","journal-title":"Nature"},{"issue":"8","key":"1975_CR190","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1212\/WNL.0000000000003636","volume":"88","author":"S Spina","year":"2017","unstructured":"Spina S et al (2017) Frontotemporal dementia with the V337M MAPT mutation: Tau-PET and pathology correlations. Neurology 88(8):758\u2013766","journal-title":"Neurology"},{"issue":"10","key":"1975_CR191","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/S1474-4422(15)00093-9","volume":"14","author":"S Teipel","year":"2015","unstructured":"Teipel S et al (2015) Multimodal imaging in Alzheimer\u2019s disease: validity and usefulness for early detection. Lancet Neurol 14(10):1037\u20131053","journal-title":"Lancet Neurol"},{"issue":"11","key":"1975_CR192","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1016\/j.neurobiolaging.2008.10.008","volume":"31","author":"E Terriere","year":"2010","unstructured":"Terriere E et al (2010) 5-(123)I-A-85380 binding to the alpha4beta2-nicotinic receptor in mild cognitive impairment. Neurobiol Aging 31(11):1885\u20131893","journal-title":"Neurobiol Aging"},{"issue":"4","key":"1975_CR193","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/ana.410300410","volume":"30","author":"RD Terry","year":"1991","unstructured":"Terry RD et al (1991) Physical basis of cognitive alterations in Alzheimer\u2019s disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 30(4):572\u2013580","journal-title":"Ann Neurol"},{"issue":"6","key":"1975_CR194","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1002\/syn.21541","volume":"66","author":"RJ Tyacke","year":"2012","unstructured":"Tyacke RJ et al., Evaluation and initial in vitro and ex vivo characterization of the potential positron emission tomography ligand. BU99008 (2-(4,5-dihydro-1H-imidazol-2-yl)-1- methyl-1H-indole), for the imidazoline(2) binding site. Synapse, 2012. 66(6): 542\u2013551","journal-title":"Synapse"},{"issue":"3","key":"1975_CR195","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/ana.22068","volume":"68","author":"R Vandenberghe","year":"2010","unstructured":"Vandenberghe R et al (2010) 18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial. Ann Neurol 68(3):319\u2013329","journal-title":"Ann Neurol"},{"issue":"5","key":"1975_CR196","first-page":"797","volume":"38","author":"T Vander Borght","year":"1997","unstructured":"Vander Borght T et al (1997) Cerebral metabolic differences in Parkinson\u2019s and Alzheimer\u2019s diseases matched for dementia severity. J Nucl Med 38(5):797\u2013802","journal-title":"J Nucl Med"},{"issue":"5","key":"1975_CR197","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1007\/s00259-013-2681-7","volume":"41","author":"VL Villemagne","year":"2014","unstructured":"Villemagne VL et al (2014) In vivo evaluation of a novel tau imaging tracer for Alzheimer\u2019s disease. Eur J Nucl Med Mol Imaging 41(5):816\u2013826","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"8","key":"1975_CR198","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/nrn1722","volume":"6","author":"A Volterra","year":"2005","unstructured":"Volterra A, Meldolesi J (2005) Astrocytes, from brain glue to communication elements: the revolution continues. Nat Rev Neurosci 6(8):626\u2013640","journal-title":"Nat Rev Neurosci"},{"issue":"10","key":"1975_CR199","doi-asserted-by":"publisher","first-page":"4778","DOI":"10.1021\/acs.jmedchem.6b00166","volume":"59","author":"AM Walji","year":"2016","unstructured":"Walji AM et al (2016) Discovery of 6-(Fluoro-(18)F)-3-(1H-pyrrolo[2,3-c]pyridin-1-yl)isoquinolin-5-amine ([(18)F]-MK-6240): a positron emission tomography (PET) imaging agent for quantification of neurofibrillary tangles (NFTs). J Med Chem 59(10):4778\u20134789","journal-title":"J Med Chem"},{"issue":"6","key":"1975_CR200","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.apradiso.2012.03.011","volume":"70","author":"M Wang","year":"2012","unstructured":"Wang M, Gao M, Zheng QH (2012) Fully automated synthesis of PET TSPO radioligands [11C]DAA1106 and [18F]FEDAA1106. Appl Radiat Isot 70(6):965\u2013973","journal-title":"Appl Radiat Isot"},{"issue":"1","key":"1975_CR201","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/mds.26834","volume":"32","author":"JL Whitwell","year":"2017","unstructured":"Whitwell JL et al (2017) [18 F]AV-1451 tau positron emission tomography in progressive supranuclear palsy. Mov Disord 32(1):124\u2013133","journal-title":"Mov Disord"},{"issue":"1","key":"1975_CR202","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1001\/archneurol.2008.511","volume":"66","author":"CA Wiley","year":"2009","unstructured":"Wiley CA et al (2009) Carbon 11-labeled pittsburgh compound B and carbon 11-labeled (R)-PK11195 positron emission tomographic imaging in Alzheimer disease. Arch Neurol 66(1):60\u201367","journal-title":"Arch Neurol"},{"issue":"6","key":"1975_CR203","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.jalz.2012.11.008","volume":"9","author":"CF Xia","year":"2013","unstructured":"Xia CF et al (2013) [(18)F]T807, a novel tau positron emission tomography imaging agent for Alzheimer\u2019s disease. Alzheimers Dement 9(6):666\u2013676","journal-title":"Alzheimers Dement"},{"issue":"10","key":"1975_CR204","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.biopsych.2008.04.021","volume":"64","author":"F Yasuno","year":"2008","unstructured":"Yasuno F et al (2008) Increased binding of peripheral benzodiazepine receptor in Alzheimer\u2019s disease measured by positron emission tomography with [11C]DAA1106. Biol Psychiatry 64(10):835\u2013841","journal-title":"Biol Psychiatry"},{"issue":"4","key":"1975_CR205","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1111\/j.1471-4159.2008.05245.x","volume":"105","author":"L Ye","year":"2008","unstructured":"Ye L et al (2008) In vitro high affinity alpha-synuclein binding sites for the amyloid imaging agent PIB are not matched by binding to Lewy bodies in postmortem human brain. J Neurochem 105(4):1428\u20131437","journal-title":"J Neurochem"},{"issue":"12","key":"1975_CR206","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1111\/j.1468-1331.2007.01977.x","volume":"14","author":"SW Yong","year":"2007","unstructured":"Yong SW et al (2007) A comparison of cerebral glucose metabolism in Parkinson\u2019s disease, Parkinson\u2019s disease dementia and dementia with Lewy bodies. Eur J Neurol 14(12):1357\u20131362","journal-title":"Eur J Neurol"},{"issue":"2","key":"1975_CR207","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3174\/ajnr.A1357","volume":"30","author":"Y Yuan","year":"2009","unstructured":"Yuan Y, Gu ZX, Wei WS (2009) Fluorodeoxyglucose-positron-emission tomography, single-photon emission tomography, and structural MR imaging for prediction of rapid conversion to Alzheimer disease in patients with mild cognitive impairment: a meta-analysis. AJNR Am J Neuroradiol 30(2):404\u2013410","journal-title":"AJNR Am J Neuroradiol"},{"key":"1975_CR208","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12974-015-0236-5","volume":"12","author":"J Zhang","year":"2015","unstructured":"Zhang J (2015) Mapping neuroinflammation in frontotemporal dementia with molecular PET imaging. J Neuroinflammation 12:108","journal-title":"J Neuroinflammation"},{"issue":"2","key":"1975_CR209","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/j.1742-1241.2011.02845.x","volume":"66","author":"S Zhang","year":"2012","unstructured":"Zhang S et al (2012) Diagnostic accuracy of 18 F-FDG and 11 C-PIB-PET for prediction of short-term conversion to Alzheimer\u2019s disease in subjects with mild cognitive impairment. Int J Clin Pract 66(2):185\u2013198","journal-title":"Int J Clin Pract"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00702-019-01975-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-019-01975-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-019-01975-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,11]],"date-time":"2022-09-11T21:27:24Z","timestamp":1662931644000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-019-01975-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,14]]},"references-count":209,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["1975"],"URL":"https:\/\/doi.org\/10.1007\/s00702-019-01975-4","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,14]]},"assertion":[{"value":"23 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declared no potential conflicts of interest with respect to the research, authorship and\/or publication of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional review boards and the local research ethics committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standard"}},{"value":"Informed consent was obtained for all studies involving human participants.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}